Statins in coronavirus outbreak: It's time for experimental and clinical studies
- PMID: 32289478
- PMCID: PMC7151298
- DOI: 10.1016/j.phrs.2020.104803
Statins in coronavirus outbreak: It's time for experimental and clinical studies
Conflict of interest statement
Declaration of Competing Interest The authors declare no conflicts of interest.
References
-
- Episcopio D., Aminov S., Benjamin S., Germain G., Datan E., Landazuri J., Lockshin R.A., Zakeri Z. Atorvastatin restricts the ability of influenza virus to generate lipid droplets and severely suppresses the replication of the virus. FASEB J. 2019;33:9516–9525. doi: 10.1096/fj.201900428RR. - DOI - PMC - PubMed
-
- Hui K.P., Kuok D.I., Kang S.S., Li H.S., Ng M.M., Bui C.H., Peiris J.S., Chan R.W., Chan M.C. Modulation of sterol biosynthesis regulates viral replication and cytokine production in influenza A virus infected human alveolar epithelial cells. Antiviral Res. 2015;119:1–7. doi: 10.1016/j.antiviral.2015.04.005. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
